Rafferty Asset Management
TYRA icon

Rafferty Asset Management’s Tyra Biosciences TYRA Stock Holding History

Rafferty Asset Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.33M Buy
34,856
+19,401
+126% +$628K 0.01% 699
2025
Q4 		$406K Buy
+15,455
New +$284K ﹤0.01% 941

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Rafferty Asset Management's TYRA Position: Q1 2026 in Review

Rafferty Asset Management increased its Tyra Biosciences (TYRA) stake by 126% in Q1 2026, buying an estimated $628K and bringing the position to 34,856 shares worth $1.33M. The position accounts for 0.01% of the portfolio, ranked #699.

Rafferty Asset Management first reported a position in TYRA in Q4 2025 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Rafferty Asset Management held 34,856 shares of Tyra Biosciences worth $1.33M as of Q1 2026.
  • Rafferty Asset Management bought 19,401 Tyra Biosciences shares in Q1 2026, an estimated $628K.
  • Tyra Biosciences made up 0.01% of Rafferty Asset Management's portfolio in Q1 2026, its #699 holding.
  • Rafferty Asset Management first reported a position in Tyra Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.